# ILEVRO

NDC: 0078-0743
Generic name: nepafenac
Labeler / Manufacturer: Novartis Pharmaceuticals Corporation
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: SUSPENSION/ DROPS
Routes: OPHTHALMIC
Marketing started: 20121220

FDA application: NDA203491

## Active ingredients

- NEPAFENAC: 3 mg/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0078-0743"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0078-0743
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=f089b583-0310-4ca8-8d41-52b06b08d1ed